- Tytuł:
- Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases January 2022 22(1):110-122
Czasopismo naukowe